{"id":30883,"date":"2014-09-11T07:01:03","date_gmt":"2014-09-11T11:01:03","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=30883"},"modified":"2014-09-11T07:01:03","modified_gmt":"2014-09-11T11:01:03","slug":"boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883","title":{"rendered":"Boston Scientific Corporation (NYSE:BSX) To Present Data At Transcatheter Cardiovascular Therapeutics Meeting To Reinforce Its Commitment On Interventional Cardiology"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 09\/11\/2014 (wallstreetpr) \u2013 Medical device manufacturer, <strong>Boston Scientific Corporation (NYSE:BSX)<\/strong> would present data at the 26<sup>th<\/sup> Transcatheter Cardiovascular Therapeutics or TCT meeting to reinforce its commitment towards the development of innovative treatment in interventional cardiology.<\/p>\n<p style=\"text-align: justify;\"><strong>Results To Be Shared<\/strong><\/p>\n<p style=\"text-align: justify;\">Boston Scientific Corporation (NYSE:BSX)\u00a0disclosed that it would share the results from over a dozen clinical trials during the annual meeting to be held from September 13 \u2013 17 in Washington and conducted by the Cardiovascular Research Foundation, a <a href=\"http:\/\/finance.yahoo.com\/news\/boston-scientific-announces-schedule-presentations-130000697.html\" target=\"_blank\">statement<\/a> from the company said.<\/p>\n<p style=\"text-align: justify;\">Boston Scientific said that it was fully committed to exploring the ways and means to find how its technologies could provide value-driven solutions for patients affected by cardiovascular disease. It plans to share data in the meeting to further carry on the body of proof illustrating the clinical value of its solutions that would help interventional cardiologists to face the changing requirements of their patients.<\/p>\n<p style=\"text-align: justify;\">The medical device maker said that the most common nature of heart disease, Coronary artery disease, is not only rampant but also expensive. It cost about $108 billion in the U.S. for medications, services and lost productivity since about 380,000 American dies every year due to coronary artery disease. Therefore, there was a continuing requirement for new technologies and therapies to face the growing worldwide problem.<\/p>\n<p style=\"text-align: justify;\"><strong>Key Data Presentations<\/strong><\/p>\n<p style=\"text-align: justify;\">Boston Scientific Corporation (NYSE:BSX)\u00a0said that it would present data during oral sessions, as well as, posters during the meeting. It plans to poster present its clinical and preclinical studies involving coronary artery multiple stent platforms. The four-year outcome of its Platinum Small Vessel and Long Lesion study and two-year outcome of its Taxus Element Post-Approval Surveillance Trial would be shared during the meeting.<\/p>\n<p style=\"text-align: justify;\">Similarly, other outcomes on Aortic Valves from the REPRISE clinical study would also be shared in the meeting.\u00a0Boston Scientific Corporation (NYSE:BSX) has one-year and two-year outcomes on REPRISE. The company has also lined up its speakers like Professor Ian Meredith, Vivek Reddy, David Holmes Jr., Mathew Price, George Hanzel and David Kandzari to present the outcome of different studies.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 09\/11\/2014 (wallstreetpr) \u2013 Medical device manufacturer, Boston Scientific Corporation (NYSE:BSX) would present data at the 26th Transcatheter Cardiovascular Therapeutics or TCT meeting to [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":25594,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264,263],"tags":[2960,8956,8959,8958,8954,8957,1020,8955],"stock_ticker":[],"class_list":["post-30883","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","category-technology","tag-boston-scientific-corporation-nysebsx","tag-david-holmes-jr","tag-david-kandzari","tag-george-hanzel","tag-ian-meredith","tag-mathew-price","tag-nysebsx","tag-vivek-reddy","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Boston Scientific Corporation (NYSE:BSX) To Present Data At Transcatheter Cardiovascular Therapeutics Meeting To Reinforce Its Commitment On Interventional Cardiology - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Boston Scientific Corporation (NYSE:BSX) To Present Data At Transcatheter Cardiovascular Therapeutics Meeting To Reinforce Its Commitment On Interventional Cardiology - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 09\/11\/2014 (wallstreetpr) \u2013 Medical device manufacturer, Boston Scientific Corporation (NYSE:BSX) would present data at the 26th Transcatheter Cardiovascular Therapeutics or TCT meeting to [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-09-11T11:01:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Boston-Scientific-Corporation.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"352\" \/>\n\t<meta property=\"og:image:height\" content=\"143\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Van Bettauer\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Van Bettauer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883\"},\"author\":{\"name\":\"Van Bettauer\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d\"},\"headline\":\"Boston Scientific Corporation (NYSE:BSX) To Present Data At Transcatheter Cardiovascular Therapeutics Meeting To Reinforce Its Commitment On Interventional Cardiology\",\"datePublished\":\"2014-09-11T11:01:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883\"},\"wordCount\":361,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Boston-Scientific-Corporation.jpg\",\"keywords\":[\"Boston Scientific Corporation (NYSE:BSX)\",\"David Holmes Jr\",\"David Kandzari\",\"George Hanzel\",\"Ian Meredith\",\"Mathew Price\",\"NYSE:BSX\",\"Vivek Reddy\"],\"articleSection\":[\"Health\",\"Technology\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883\",\"name\":\"Boston Scientific Corporation (NYSE:BSX) To Present Data At Transcatheter Cardiovascular Therapeutics Meeting To Reinforce Its Commitment On Interventional Cardiology - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Boston-Scientific-Corporation.jpg\",\"datePublished\":\"2014-09-11T11:01:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Boston-Scientific-Corporation.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Boston-Scientific-Corporation.jpg\",\"width\":352,\"height\":143},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Boston Scientific Corporation (NYSE:BSX) To Present Data At Transcatheter Cardiovascular Therapeutics Meeting To Reinforce Its Commitment On Interventional Cardiology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d\",\"name\":\"Van Bettauer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g\",\"caption\":\"Van Bettauer\"},\"description\":\"Van Bettauer is a financial aficionado from Vancouver, British Columbia. He currently studies at UBC, pursuing a Bachelors of Science degree. Van has been freelance writing for many years, specializing in copywriting, report writing and article writing. The combination of his scientific studies and writing experience brings a new and fresh perspective to the financial world. Visit Bettauer's Google+ page at the following address: https:\/\/plus.google.com\/100770875710593766367\/posts\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/van-bettauer\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Boston Scientific Corporation (NYSE:BSX) To Present Data At Transcatheter Cardiovascular Therapeutics Meeting To Reinforce Its Commitment On Interventional Cardiology - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883","og_locale":"en_US","og_type":"article","og_title":"Boston Scientific Corporation (NYSE:BSX) To Present Data At Transcatheter Cardiovascular Therapeutics Meeting To Reinforce Its Commitment On Interventional Cardiology - Wall Street PR","og_description":"Boston, MA 09\/11\/2014 (wallstreetpr) \u2013 Medical device manufacturer, Boston Scientific Corporation (NYSE:BSX) would present data at the 26th Transcatheter Cardiovascular Therapeutics or TCT meeting to [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-09-11T11:01:03+00:00","og_image":[{"width":352,"height":143,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Boston-Scientific-Corporation.jpg","type":"image\/jpeg"}],"author":"Van Bettauer","twitter_misc":{"Written by":"Van Bettauer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883"},"author":{"name":"Van Bettauer","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d"},"headline":"Boston Scientific Corporation (NYSE:BSX) To Present Data At Transcatheter Cardiovascular Therapeutics Meeting To Reinforce Its Commitment On Interventional Cardiology","datePublished":"2014-09-11T11:01:03+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883"},"wordCount":361,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Boston-Scientific-Corporation.jpg","keywords":["Boston Scientific Corporation (NYSE:BSX)","David Holmes Jr","David Kandzari","George Hanzel","Ian Meredith","Mathew Price","NYSE:BSX","Vivek Reddy"],"articleSection":["Health","Technology"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883","url":"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883","name":"Boston Scientific Corporation (NYSE:BSX) To Present Data At Transcatheter Cardiovascular Therapeutics Meeting To Reinforce Its Commitment On Interventional Cardiology - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Boston-Scientific-Corporation.jpg","datePublished":"2014-09-11T11:01:03+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Boston-Scientific-Corporation.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Boston-Scientific-Corporation.jpg","width":352,"height":143},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/boston-scientific-corporation-nysebsx-to-present-data-at-transcatheter-cardiovascular-therapeutics-meeting-to-reinforce-its-commitment-on-interventional-cardiology-30883#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Boston Scientific Corporation (NYSE:BSX) To Present Data At Transcatheter Cardiovascular Therapeutics Meeting To Reinforce Its Commitment On Interventional Cardiology"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d","name":"Van Bettauer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g","caption":"Van Bettauer"},"description":"Van Bettauer is a financial aficionado from Vancouver, British Columbia. He currently studies at UBC, pursuing a Bachelors of Science degree. Van has been freelance writing for many years, specializing in copywriting, report writing and article writing. The combination of his scientific studies and writing experience brings a new and fresh perspective to the financial world. Visit Bettauer's Google+ page at the following address: https:\/\/plus.google.com\/100770875710593766367\/posts","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/van-bettauer"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/30883","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=30883"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/30883\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/25594"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=30883"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=30883"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=30883"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=30883"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}